Erin Sharoni joins Ethics Talk to discuss her article: “Which Concepts Are Key to Transitioning From Nonhuman Animal Models to Engineered Microphysiological Systems in Biomedical Research?”

Laurie Sellars joins Ethics Talk to discuss her article, coauthored with Dr Jeff Sebo: “How Should Treatment of Animals Beyond the Lab Factor Into Institutional Review?”

Dr Aysha Akhtar joins Ethics Talk to discuss her article, coauthored with Mikalah Singer, “With What Should We Replace Nonhuman Animals in Biomedical Research Protocols?”

Authors argue that use of nonhuman primates and other animals is unjustified.

Underrepresentation of individuals with limited English proficiency who speak Spanish is ongoing in phase 3 biomedical clinical trials and exacerbates health inequity.

La subrepresentación de personas con dominio limitado del inglés que hablan español está en curso en ensayos clínicos biomédicos de fase 3 y exacerba la inequidad en salud.

The possibility of nonhuman animals becoming legal persons and having better protections under the federal Animal Welfare Act is front and center here.

Historically, most discussions about nonhuman animal experimentation consider what has become known as the 3 R’s: refinement, reduction, and replacement.

A transition to organoids and organ-on-a-chip technologies would signal a paradigm shift in biomedical research.

Humans make critical decisions about nonhuman lab animals outside the lab: during breeding, transportation, and end-of-study protocols.